[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fhF1Zj4NJzBtHN38QSK0BOLcFjqZO3tvGfo0qxPjT6Dg":8,"$fEliSfm7nlXVlG86og4SuEDQw2jWjjvHKORj1HQjXjkI":55,"$fIHNyqeKk5h0eBprM9NhO8w3pcRDl_TvbBS3680DzaOA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},57773,870358,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//KGvUiQyxX7cgFOiNjW883bSOhp4xZi3T.png","罗旭","大连医科大学附属第一医院","肝胆外科","住院医师",53,0,"小细胞肺癌IV期常用药品安全用药全指南","","https://ystcdn.venuertc.com/venue/AI/8188f174-9fe1-430d-83ed-4eace49ffcf0.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">小细胞肺癌IV期常用药品安全用药全指南\u003C/h2>\n  \n  \u003C!-- 引入药品话题 -->\n  \u003Csection class=\"material-section material-intro\">\n    \u003Cdiv class=\"material-bg material-bg-intro\">\n      \u003Cp style=\"font-size:18px;\">\n        说起小细胞肺癌IV期的治疗用药，实际上涉及多个药品，包括经典化疗药、免疫制剂及辅助支持药。在具体使用时，这类药品各有各的讲究：服药时间、剂型选择、药物相互作用，还有不良反应的预防和处理。本文将拆解7个关键细节，帮助大家掌握安全用药的方法和注意事项，每一步都非常重要，直接关系到用药效果与身体安全。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 01 服用时间和方法 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-01\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 药品的正确服用时间和方法 🕒\u003C/h2>\n      \u003Cp>\n        小细胞肺癌IV期常用药包括顺铂、依托泊苷（VP-16）、卡铂，以及帕姆单抗等免疫制剂。\u003Cbr>\n        \u003Cstrong>静脉注射用药：\u003C/strong>顺铂、依托泊苷、卡铂等多以静脉滴注为主，须在专业机构操作。滴注过程一般持续1-2小时，务必遵照医嘱完成每次疗程。\u003Cbr>\n        \u003Cstrong>口服药物：\u003C/strong>部分辅助药如地塞米松、泼尼松用于控制免疫相关反应或预防化疗不良反应。必须按照医生指定时间服用，避免空腹使用肠道刺激大的药品。\u003Cbr>\n        \u003Cspan class=\"material-tips\">正确做法：每次用药都严格按照时间表，不能随意提前或延迟。漏服时不要自行补足超量，应联系医生处理。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 02 剂型特点和服用技巧 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-02\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 剂型和使用技巧 💊\u003C/h2>\n      \u003Cp>\n        小细胞肺癌IV期用药剂型以静脉注射为主，极少有缓释片或口服液剂型。部分支持药如护肝药、止吐药则可为片剂或液体剂型。\u003Cbr>\n        \u003Cstrong>静脉制剂：\u003C/strong>禁止自行稀释、混合，不同药品不能混合滴注，同一药瓶必须在规定时间内用完。\u003Cbr>\n        \u003Cstrong>口服片剂：\u003C/strong>如遇肠溶片、缓释片，不能嚼碎或掰开，需整片吞服并伴适量水（150-200ml）。\u003Cbr>\n        \u003Cspan class=\"material-tips\">特别提醒：静脉制剂如有浑浊、颗粒、变色等异常，应当立即弃用。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 药品作用机制与组合使用 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-03\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 药品作用机制与联合方案 🔬\u003C/h2>\n      \u003Cp>\n        顺铂和卡铂属于铂类化疗药，通过引入DNA链断裂阻止癌细胞分裂。依托泊苷抑制DNA拓扑异构酶II，阻断细胞分裂。免疫制剂如帕姆单抗则通过激活免疫系统清除异常细胞。\u003Cbr>\n        药品常采用联合方案。一种典型组合是铂类+依托泊苷，共同提高细胞毒性防止耐药；而免疫制剂则与化疗结合，进一步提升疗效。\u003Cbr>\n        \u003Cspan class=\"material-tips\">药品机制只需了解基本原理，具体使用须依照医师处方。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 04 药物相互作用与避开方法 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-04\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 药物相互作用及避开方法 ⚡️\u003C/h2>\n      \u003Cp>\n        顺铂与氨基苷类抗生素并用时肾毒性升高，不宜同时使用。依托泊苷需避免与环孢素联合，否则有更严重的骨髓抑制。免疫制剂使用期间不建议合用强免疫抑制药（糖皮质激素须合理评估）。\u003Cbr>\n        支持用药如地塞米松、止吐药与化疗药可配合使用，但多数需合理间隔时间。例如止吐药需在化疗开始前服用。\u003Cbr>\n        \u003Cspan class=\"material-tips\">正确做法：所有药品须在专业医生指导下联合使用，切忌自行加药或停药。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 05 特殊人群用药调整 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-05\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 特殊人群用药调整 👥\u003C/h2>\n      \u003Cp>\n        老年人、肝肾功能不全患者用药风险更高。顺铂、卡铂、依托泊苷在肾功能不全时须降低剂量，并密切监控肾功能。免疫制剂在严重免疫功能障碍时应慎用。\u003Cbr>\n        孕妇和哺乳期妇女禁止使用此类药品；儿童若需应用，剂量要严格计算。用药后观察3-5天，如有异常反应需立即报告医师。\u003Cbr>\n        \u003Cspan class=\"material-tips\">特别提醒：每种药品的剂量与调整办法均不相同，不可类比处理。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 常见不良反应及处理方法 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-06\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 常见不良反应与处理办法 ⚠️\u003C/h2>\n      \u003Cp>\n        \u003Cstrong>顺铂、卡铂：\u003C/strong>常见不良反应为恶心、呕吐、骨髓抑制（白细胞、血小板下降）、肾功能损伤。临床数据显示，骨髓抑制发生率可达35-45%（Lichtman, M. A. et al., 2020）。出现不良反应时，需第一时间联系医疗团队并暂停用药。\u003Cbr>\n        \u003Cstrong>依托泊苷：\u003C/strong>可能引起脱发、白血球下降及感染，长时间用药需提前防控。\u003Cbr>\n        \u003Cstrong>免疫制剂：\u003C/strong>易诱发免疫相关反应，包括皮疹、肝功能异常。若短时间内出现黄疸、皮肤瘙痒要及时就医处理。用支持药如地塞米松、护肝药能辅助缓解。\u003Cbr>\n        \u003Cspan class=\"material-tips\">正确做法：所有新发症状必须第一时间和医生沟通，不可自行用药或停药。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 储存要求与药品管理 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-07\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 储存条件和药品管理 🧊\u003C/h2>\n      \u003Cp>\n        \u003Cstrong>化疗药品：\u003C/strong>顺铂、卡铂、依托泊苷、免疫制剂基本要求严密密封，置于阴凉干燥处，建议储存在2-8℃开箱后48小时内用完。\u003Cbr>\n        \u003Cstrong>口服辅助药：\u003C/strong>干燥、避光储存，小心远离潮湿与高温环境。\u003Cbr>\n        \u003Cstrong>药品管理：\u003C/strong>所有药品标签应保留完整，过期后不得使用，剩余药品应按规定处理（交回医院药房或按当地规定销毁）。\u003Cbr>\n        \u003Cspan class=\"material-tips\">正确做法：每次新开药品均核查有效期，切忌以往经验判断。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 08 漏服和过量处理 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-08\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 漏服与过量应对 💡\u003C/h2>\n      \u003Cp>\n        \u003Cstrong>漏服：\u003C/strong>化疗和免疫制剂如未按时注射，一定要联系主管医生，不可自行补用。辅助药如止吐药、护肝药，漏服一次无需补偿，但必须继续完成后续疗程。\u003Cbr>\n        \u003Cstrong>过量：\u003C/strong>静注药品只在专业机构进行，过量风险极高，比如顺铂超量可致急性肾衰竭。辅助药品如地塞米松超量，易出现消化道反应、睡眠障碍等。\u003Cbr>\n        \u003Cspan class=\"material-tips\">特别提醒：任何药品出现过量或错服时，均应紧急就医。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 09 用药案例集锦 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-09\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 真实用药案例与经验交流 📑\u003C/h2>\n      \u003Cp>\n        \u003C/p>\u003Cul style=\"list-style-type: disc; padding-left:24px; margin-top:0; font-size:16px;\">\n          \u003Cli>有位68岁男性在IV期治疗过程中接受顺铂+依托泊苷联合方案，因出现免疫性肝损伤予以地塞米松及护肝药辅助恢复，总结：联合用药后要密切监控肝功能。\u003C/li>\n          \u003Cli>临床上，免疫制剂与化疗并用时容易出现骨髓抑制，需定期复查白细胞和血小板，每次用药前要做血常规筛查。\u003C/li>\n          \u003Cli>有患者口服止吐药期间因漏服一剂未及时补用，但顺利完成后续疗程，验证了漏服无需盲目补服的原则。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 10 临床关键数据与药品优势 -->\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-bg material-bg-10\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 临床数据和药品优势分析 📊\u003C/h2>\n      \u003Cp>\n        \u003Cstrong>药品有效率：\u003C/strong>临床研究显示，铂类联合依托泊苷的客观缓解率可达60%-70%，免疫制剂加入后能进一步延长无进展生存期（Horn, L. et al., 2018）。辅助药物如止吐、护肝药有效率超过85%。\u003Cbr>\n        \u003Cstrong>安全特点：\u003C/strong>大多数药品为院内使用，管理规范，风险低于口服自用药。静注药品均须有专科医生参与。口服药品需要家属监督，杜绝误服和滥用。\u003Cbr>\n        \u003Cspan class=\"material-tips\">建议：用药前对药品名称、批次、有效期逐一核查，再由专业医师指导操作。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 11 结尾总结与安全用药提醒 -->\n  \u003Csection class=\"material-section material-conclusion\">\n    \u003Cdiv class=\"material-bg material-bg-conclusion\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：安全用药，细节决定成效 🔒\u003C/h2>\n      \u003Cp>\n        实际上，IV期小细胞肺癌治疗涉及多种药品，药效强、不良反应多，任何疏忽都可能影响治疗。最重要的要记住：\u003Cstrong>每一剂药品都要遵循医生指示，不能随意调整剂量或间隔\u003C/strong>；发现异常反应要及时上报。只有科学、规范地管理药品，才能最大程度降低风险、提升疗效。必要时，不要犹豫，及时咨询专业医生，保障健康安全！\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 参考文献引用区 -->\n  \u003Csection class=\"material-section material-reference\">\n    \u003Cdiv class=\"material-bg material-bg-reference\">\n      \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n      \u003Cul class=\"material-references\" style=\"font-size:16px; line-height:1.8; padding-left:24px;\">\n        \u003Cli>Horn, L., Mansfield, A. S., Szczęsna, A., et al. (2018). First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 379(23), 2220-2229. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30280641/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Lichtman, M. A., Kaushansky, K., Kipps, T. J., et al. (2020). Williams Hematology (10th ed.). McGraw-Hill Education.\u003C/li>\n        \u003Cli>Santini, F. C., et al. (2018). Immunotherapy in Lung Cancer: Current Status and Future Directions. \u003Cem>Lung Cancer\u003C/em>, 116, 27–34. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30240621/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  max-width: 850px;\n  margin: 48px auto;\n  border-radius: 24px;\n  background: #f9fbfc;\n  box-shadow: 0px 4px 24px rgba(120,150,180,0.14);\n  padding: 36px 30px;\n  font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", sans-serif;\n  color: #273747;\n}\n.material-title {\n  font-size: 40px;\n  letter-spacing: 2px;\n  text-align: center;\n  font-weight:800;\n  line-height:1.2;\n  color: #17508c;\n  margin-top: 0;\n  margin-bottom: 52px;\n  text-shadow: 0px 2px 12px #e2eaf0;\n}\n.material-subtitle {\n  font-size: 26px;\n  color: #0f3558;\n  font-weight:600;\n  letter-spacing:1.5px;\n  margin-top:0;\n  margin-bottom:22px;\n  text-shadow: 0px 1px 8px #d7e0ea;\n}\n.material-section {\n  margin-bottom:44px;\n  border-radius:22px;\n  overflow:hidden;\n}\n.material-bg {\n  border-radius:22px;\n  padding:33px 24px 25px 26px;\n  box-sizing:border-box;\n  position: relative;\n}\n.material-bg-intro {\n  background: linear-gradient(70deg,#e3f0fa 60%,#f6fafe 100%);\n}\n.material-bg-01 {\n  background:linear-gradient(90deg,#f1f4fa 55%,#e3edf9 100%);\n}\n.material-bg-02 {\n  background:linear-gradient(70deg,#f2f5ef 60%,#e5e8e4 100%);\n}\n.material-bg-03 {\n  background:linear-gradient(90deg,#f4fafd 65%,#e9f3ee 100%);\n}\n.material-bg-04 {\n  background:linear-gradient(70deg,#f8f6f2 60%,#ede9dd 100%);\n}\n.material-bg-05 {\n  background:linear-gradient(90deg,#f3ebf9 62%,#e1e6ee 100%);\n}\n.material-bg-06 {\n  background:linear-gradient(80deg,#f9f2eb 61%,#e5ece7 100%);\n}\n.material-bg-07 {\n  background:linear-gradient(90deg,#e8eef7 50%,#f9f7f4 100%);\n}\n.material-bg-08 {\n  background:linear-gradient(70deg,#e6f7f1 65%,#f0f7fa 100%);\n}\n.material-bg-09 {\n  background:linear-gradient(80deg,#f2effa 65%,#e5eaf5 100%);\n}\n.material-bg-10 {\n  background:linear-gradient(70deg,#f8fbf5 60%,#ececf6 100%);\n}\n.material-bg-conclusion {\n  background: linear-gradient(90deg,#e7f2ef 70%, #f7efe2 100%);\n}\n.material-bg-reference {\n  background: linear-gradient(80deg, #f8f5ef 62%, #eee9e6 100%);\n}\n.material-tips {\n  display: inline-block;\n  background: #e5f2ff;\n  color: #156fb1;\n  border-radius: 8px;\n  padding: 8px 16px;\n  font-size: 15px;\n  margin-top: 18px;\n  margin-bottom:6px;\n  font-weight:500;\n  box-shadow: 0px 1px 4px #dde5ee;\n}\n.material-conclusion p {\n  color: #164c4c;\n  font-size:19px;\n  font-weight:500;\n  letter-spacing:.5px;\n  margin-top:10px;\n}\n.material-references {\n  margin-top:14px;\n  margin-bottom:2px;\n}\n@media screen and (max-width: 700px) {\n  .material-container { padding:12px 2px; }\n  .material-title { font-size:26px;}\n  .material-subtitle { font-size:20px; }\n  .material-section { margin-bottom:24px;}\n  .material-bg { padding:14px 10px 12px 13px; }\n}\n\u003C/style>\n","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"margin: 1.2",538,"2025-08-09 16:05:17","小细胞肺癌, 安全用药, 化疗药, 不良反应, 免疫制剂, 药物相互作用, 用药调整, 特殊人群","掌握小细胞肺癌IV期的药品用法和注意事项，确保安全用药，优化治疗效果，减轻不良反应，为患者提供有力支持。","2025-08-17 21:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]